This is the authors' abstract. We don't add key points for this paper.
Beta2-AR antagonist seemed to be the most cytotoxic β-blocker on non-stimulated cancer cells. Propranolol and ICI118,551 were more effective than atenolol in inhibiting invasion and migration of non-stimulated MCF7 and HT-29 cells; ICI118,551 being the most potent. Concordantly, β2-selective blockage seemed to be more effective for non-stimulated cells. Effect of the selective β-AR antagonists showed variation depending on the concentration, incubation time, and histological origin of cells.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
İşeri et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: